• Worst Pills, Best Pills



• Health Letter



• Health Links



• Activist Courses



• Take Action!



• Drug Safety



• Healthcare Delivery



• Medical Devices



• Food Safety



• Occupational Health

Publications:

» (6/27/07) Testimony on State Laws Requiring Disclosure of Pharmaceutical Company Payments to Physicians (HRG Publication #1817) » (4/9/07) Letter to the FDA concerning Pfizer's 2 ½ minute television advertisement for Celebrex (HRG Publication #1803) » (3/20/07) Article in JAMA: Pharmaceutical Company Payments to Physicians (HRG Publication #1801) » (10/28/02) Comments to FDA on First Amendment Issues, specifically related to FDA enforcement of drug advertising laws and regulations (HRG Publication #1645) » (10/7/02) An Outbreak of Web Sites Selling Ciprofloxacin Following an Outbreak of Anthrax by Mail (HRG Publication #1641) » (9/13/02) Response to FDA Request for Comments on First Amendment Issues (HRG Publication #1638) » (2/14/02) Direct-To-Consumer Advertising--Education or Emotion Promotion? (HRG Publication #1610) » (7/24/01) Testimony before the Subcommittee on Consumer Affairs Hearing, Senate Commerce Committee on Direct-to-Consumer (DTC) Advertising. (HRG Publication #1583) » (8/9/99) Opinion appearing in USA Today concerning the promotion of off-label uses of drugs. (HRG Publication #1492A) » (8/3/99) Letter to the Department of Heath and Human Services concerning Pfizer's campaign to counter the Centers for Disease Control recommendations for treatment of ear infections. (HRG Publication #1491) » (9/28/98) Comments on proposed Food and Drug Administration survey entitled FDA: Attitudinal and Behavioral Effects of Direct-to-Consumer Advertising of Prescription Drugs. (HRG Publication #1460) » (7/29/98) Letter to USA Today, demanding action against all USA Today employees responsible for the Glaxo Wellcome Special Edition of the paper distributed at an AIDS conference and promoting Glaxo Wellcome (HRG Publication #1450) » (10/14/97) Comments on Food and Drug Administration's Draft Guidance for Industry on direct to consumer advertising. (HRG Publication #1429) » (8/13/97) Press release challenging the Clinton Administration for announcing new testing requirements for children's medications but allowing off-label prescribing to children. (HRG Publication #1423) » (7/17/97) Letter to Senators urging them to vote against an amendment to S.830 which would make it legal for companies to promote drugs and medical devices for unapproved uses. (HRG Publication #1420) » (10/1/96) Editorial by Sidney M. Wolfe in the 10/96 Vol. 11 Issue of the Journal of General Internal Medicine Entitled Why Do American Drug Companies Spend More than $12 Billion a Year Pushing Drugs? Is it Education or Promotion? (HRG Publication #1403A) » (9/5/96) HRG Letter to David Kessler Regarding Lancet Ad Discussing Demeaning Ways That Physicians Are Viewed (HRG Publication #1403) » (8/12/96) HRG Comments on Direct-to-Consumer Prescription Drug Promotion dated 5/14/96. (HRG Publication #1400) » (10/19/95) Testimony of Sidney M. Wolfe at FDA Hearing on Direct-to-Consumer Advertising of Prescription Drugs (HRG Publication #1375)

more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here.